Utility of Circulating B-Raf DNA Mutation in Serum for Monitoring Melanoma Patients Receiving Biochemotherapy

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-06-2120
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Circulating Tumour DNA for Monitoring Treatment Response to Anti-Pd-1 Immunotherapy in Melanoma Patients

Acta Dermato-Venereologica
DermatologyMedicine
2017English

A New B-Raf Inhibitor Combo for Advanced Melanoma

Oncotarget
Oncology
2018English

Circulating Cell-Free DNA in Plasma of Melanoma Patients: Qualitative and Quantitative Considerations

Clinica Chimica Acta
MedicineBiochemistryClinical Biochemistry
2011English

Targeting Mutant (V600E) B-Raf in Melanoma Interrupts Immunoediting of Leukocyte Functions and Melanoma Extravasation

Cancer Research
Cancer ResearchOncology
2007English

Detection of Circulating Melanoma Cells in the Blood of Melanoma Patients

Melanoma Research
DermatologyCancer ResearchOncology
2015English

Circulating Tumour DNA and CT Monitoring in Patients With Untreated Diffuse Large B-Cell Lymphoma: A Correlative Biomarker Study

The Lancet Oncology
Oncology
2015English

Analysis of the B-RafV600E Mutation in Cutaneous Melanoma Patients With Occupational Sun Exposure

Oncology Reports
MedicineCancer ResearchOncology
2014English

Small Molecules Against B-Raf (BRAF) Val600Glu (V600E) Single Mutation

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2015English

Quantitative Polymerase Chain Reaction Detection of Circulating DNA in Serum for Early Diagnosis of Mucormycosis in Immunocompromised Patients

Clinical Infectious Diseases
Infectious DiseasesMicrobiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy